Suppr超能文献

膀胱癌患者行根治性膀胱切除术时偶然发现前列腺癌的发生率、预测因素和生存结局。

Incidence, predictive factors and survival outcomes of incidental prostate cancer in patients who underwent radical cystectomy for bladder cancer.

机构信息

Urology Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.

Urology Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy -

出版信息

Minerva Urol Nephrol. 2021 Jun;73(3):349-356. doi: 10.23736/S2724-6051.20.03646-2. Epub 2020 Jan 30.

Abstract

BACKGROUND

The aim of this study was to analyze the incidence, preoperative findings, pathological features and prognosis in patients with incidental prostate cancer (iPCa) detected at radical cystectomy (RC) for bladder cancer (BCa).

METHODS

We retrospectively reviewed data of patients who underwent RC for BCa at our Institution between January 2005 and March 2018. Data regarding patient's history, preoperative digital rectal examination (DRE), total serum PSA level were collected from the chart review. Univariable and multivariable Cox regression models addressed the association of iPCa with recurrence-free survival (RFS) and overall survival (OS).

RESULTS

We obtained a final study cohort of 177 patients. Median age was 69 years (IQR 42-89) and 80(45.2%) patients had iPCa. Patients with iPCa had higher age, preoperative PSA levels and a significant rate of suspicious DRE (all P<0.05). Four patients had BCR during a median follow-up of 28 months (IQR 6-159) and none died for prostate cancer. In multivariable analyses adjusted for age, bladder cancer BCa pT and pN stage and LVI the ten-years RFS and OS rates were not impacted by iPCa regardless of whether it is a clinically significant cancer or not (HR=1.25, 95% CI: 0.65-2.38, P=0.51 vs. HR=1.37, 95% CI: 0.71-2.64, P=0.35) (HR=1.04, 95% CI: 0.53-1.86, P=0.89 vs. HR=1.20, 95% CI: 0.22-6.72, P=0.83).

CONCLUSIONS

iPCa is quite common in our study group and most of cases are organ-confined and well differentiated. Regardless of clinical relevance, iPCa does not have an impact on survival outcomes as BCa is driving the prognosis of these patients.

摘要

背景

本研究旨在分析在膀胱癌(BCa)根治性膀胱切除术(RC)中偶然发现的前列腺癌(iPCa)患者的发病率、术前发现、病理特征和预后。

方法

我们回顾性分析了 2005 年 1 月至 2018 年 3 月期间在我院接受 RC 治疗 BCa 的患者数据。从图表回顾中收集了患者病史、术前直肠指检(DRE)、总血清 PSA 水平等数据。单变量和多变量 Cox 回归模型探讨了 iPCa 与无复发生存率(RFS)和总生存率(OS)的关系。

结果

我们获得了一个最终的研究队列,共 177 名患者。中位年龄为 69 岁(IQR 42-89),80 名(45.2%)患者患有 iPCa。iPCa 患者年龄较大,术前 PSA 水平较高,DRE 可疑率较高(均 P<0.05)。4 名患者在中位随访 28 个月(IQR 6-159)时发生 BCR,无患者死于前列腺癌。在调整年龄、膀胱癌 BCa pT 和 pN 分期和 LVI 后,多变量分析显示,无论 iPCa 是否为临床显著癌症,10 年 RFS 和 OS 率不受影响(HR=1.25,95%CI:0.65-2.38,P=0.51 比 HR=1.37,95%CI:0.71-2.64,P=0.35)(HR=1.04,95%CI:0.53-1.86,P=0.89 比 HR=1.20,95%CI:0.22-6.72,P=0.83)。

结论

在我们的研究组中,iPCa 相当常见,大多数病例为器官局限性和分化良好的。无论临床相关性如何,iPCa 对生存结果没有影响,因为 BCa 是影响这些患者预后的主要因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验